Med Tech industry

Optimize your business decisions with our best-in-class overview of reimbursement status and strategy for medical devices in Europe

Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 14 European countries

Analysis

Reimbursement

  • Availability of procedure / reimbursement code
  • Reimbursement mechanism (diagnosis-related group or fee for service)
  • Availability of add-on reimbursement
  • Availability of innovation funding
  • Reimbursement tariffs

National funding

Willingness to pay for technology, based on:

  • Statements from national commissioners (e.g., NHS England)
  • Health Benefit Catalogues (e.g. in Spain, LEA Levels in Italy)
  • National clinical guidance (e.g. NICE in the UK, Haute Autorité de Santé in France, Socialstyrelsen in Sweden)
  • National health technology assessments in connection with reimbursement decisions (e.g. NICE for Technology Appraisal in the UK, Haute Autorité de Santé in France)
  • Specific funding frameworks (e.g., “New method” in Norway)
Strategy

Reimbursement strategy

Pathway to get reimbursement:

  • Overview of drivers and barriers for adoption
  • Overview of key reimbursement and funding pathways (including state-sponsored studies and innovation funding)
  • Detailed presentation of individual pathways (process, stakeholders, requirements, timelines)
  • Action plan

We tailor our services to fit your requirements and budget

Our solutions vary from low cost off-the-shelf EU reimbursement reports for dozens of technologies to customized reimbursement mapping, evidence and reimbursement strategy projects. Contact us to determine the most optimal solution for your business decisions

Our services cover 14 European countries, including Austria, Belgium, Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Russia, Spain, Sweden and Switzerland

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-in­ter­ven­tional procedures

Medical aids

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring and insulin injection, use of fusidial markers, radiotherapy, endoscopy and more

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • Transcatheter aortic valve implantation (TAVI) 
  • Eight minimally invasive and transcatheter mitral valve repair and replacement technologies
  • Group of peripheral vascular arterial interventions (angioplasty, angioplasty using drug-eluting balloon, stenting using bare metal and drug-eluting stents, atherectomy, periperal IVUS)
  • Robotic surgery interventions
  • Peripheral venous interventions for deep vein thrombosis and venous insufficiency
  • Coronary percutaneous revascularization (angioplasty using plain and drug-coated balloon, bare metal and drug-eluting stents, mechanical thrombectomy, percutaneous atherectomy)
  • Coronary percutaneous imaging procedures (angiography, IVUS, FFR, OCT)
  • Mechanical thrombectomy for stroke
  • Ablation of heart tissue for atrial fibrillation
  • Radiotherapy procedures (all types)

Ongoing reports:

  • Procedures on spine for intervertebral disc prolapse, vertebra fracture
  • Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Surgical and endovascular treatment of brain aneurysm
  • Hospital and out-patient remote monitoring coding and reimbursement for neurostimulators

Confidence in results

We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Get analysis results within weeks

  • Our standard turnaround time for on-demand services is 4-5 weeks for reimbursement analysis and an additional 3-4 weeks for strategy
  • You can request an "express delivery" option, if you need an analysis within 2 weeks
  • Off-the-shelf reimbursement reports are delivered immediately after payment is processed

Are you interested in learning more about how we can help you?